高報酬で影響力保持、トップ引退後の日本企業お決まりコースに変化 – 医薬品メーカーで日本最大手の武田薬品工業は今月、日本企業としては異例な内容の書簡を株主に送り、相談役に就任予定の長谷川閑史会長について、月額報酬はあるものの賞与や長期インセンティブ報酬はなく、年間報酬額が現在の約12％程度となるほか、社用車や専任秘書を置かないと説明。さらに、長谷川氏が既に同社の事業判断に「もはや」関与していないほか、相談役就任後も現役の経営陣がアドバイスを求めるケースはあるとしても「ごくまれ」と指摘した。 Bloomberg
Takeda Pharmaceutical Manufacturer, the largest pharmaceutical manufacturer and Japan’s biggest Takeda Pharmaceutical Manufacturer, will send letters of contents unusual for Japanese companies to shareholders this month and will be appointed as a counselor For Mr. Hasegawa Kimiyama, although there is monthly remuneration, there is no bonus or long-term incentive fee, the annual remuneration will be about 12% of the current amount, and it will explain that we do not have a company car or full-time secretary. In addition, Mr. Hasegawa has not been involved in the business decision of the company any longer, and even after taking office as a counselor, even if there are cases where active management seek advice, it is “extremely rare”. Bloomberg
https://www.bloomberg.co.jp/news/articles/2017-06-27/OS6WIE6K50XS01